Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2026 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
“I learned early on that if I was to survive, I had to be pro-active,” the amazing Carl Fox says.
He first learned this lesson in 1985, when the then-27-year-old gay man was told by his doctor he was now living with HIV — but not for long, according to the medical world at the time. The doctor gave him two years to live. It was a familiar sentence delivered to many gay and bi men of the period, but one Fox found himself unable to accept.
“I was told to go home and basically die,” Fox, now 63, recalls, but when he felt no different six months later, he returned to the doctor with a new message of resolve that stays with him to this day.
“I have decided not to die from this, and you can’t make me!” he recalls telling the doctor.
Fox lost his partner and far too many friends during that period and the years to follow, but he also taught himself to speak out and fight back.
“We had to fight for ourselves, and go and demand services, help, medications, everything. We had to be leaders,” Fox says, later adding that since those dark times he strives “never to be silent when fighting” for the health care rights and needs of others.
Fox’s perseverance was tested yet again six years ago when a sudden spine issue left him partially paralyzed. Dogged rehabilitation has since returned 50 percent of its former strength to his lower body, and he recently put himself to an important, albeit small, test of his abilities.
“I managed to jump about 2 inches, and can do a short, bad sprint!” he proudly reveals.
It’s the intersectionality of his never-say-die attitude along with an undying loyalty to the community that led Fox to participate in a landmark study through the University of Cincinnati’s Infectious Disease Clinic. Researchers are studying gene modification with the hope of lowering the entry of HIV into the white blood cells called lymphocytes, and laying the groundwork for a potential cure down the road.
“Within the last 12 months I have received two infusions, and am now waiting to see if it works,” Fox says. “It is a two-year study, and double blind, but in the end, they may cure this disease! Nothing tops that!”
From our Sponsors
Most Popular
The road to U=U: How science has been liberating HIV+ people for a decade
July 01 2026 12:05 PM
Newly diagnosed with HIV? Advocates share their best advice for seeking treatment
April 29 2026 3:32 PM
How to find an HIV-competent healthcare provider, according to advocates
May 19 2026 4:55 PM
Plus: Featured Video
Latest Stories
A New Once-Daily Pill to Treat HIV Just Got the FDA’s Green Light
August 31 2026 2:31 PM
Why affirming faith communities belong in the fight to end HIV
August 30 2026 8:00 AM
Navigating a new HIV diagnosis? Advocates say community is key
August 25 2026 3:33 PM
Gay Wine Weekend toasts 15 years of raising funds for HIV
August 25 2026 11:00 AM
A new HIV diagnosis doesn't have to be nerve-wracking. Advocates share their advice
July 30 2026 12:01 PM
Zero HIV Stigma Day: The epidemic we still choose to ignore
July 21 2026 7:00 AM
National HIV Prevention Day: Awareness is my superpower
July 17 2026 8:00 AM
Federal court clarifies that people with HIV can join the military again
June 03 2026 5:36 PM
Can a single infusion of immune cells suppress HIV for years?
May 11 2026 11:39 AM
National HIV advocacy group's CEO rejects claims of crisis
April 21 2026 5:14 PM
Beyond awareness: How youth leadership is reshaping the HIV response
April 10 2026 9:12 AM
Saving public health? AIDS United's new CEO has a plan
March 23 2026 9:48 AM
Struggling with daily HIV meds? Monthly shots may be the answer
March 20 2026 7:12 AM
Trending stories
Recommended Stories for You


































































